4.98
+0.26(+5.51%)
Currency In USD
| Previous Close | 4.72 |
| Open | 4.72 |
| Day High | 5.1 |
| Day Low | 4.55 |
| 52-Week High | 12.61 |
| 52-Week Low | 3.72 |
| Volume | 1.04M |
| Average Volume | 1.34M |
| Market Cap | 567M |
| PE | -2.53 |
| EPS | -1.97 |
| Moving Average 50 Days | 5.9 |
| Moving Average 200 Days | 8.66 |
| Change | 0.26 |
If you invested $1000 in Cogent Biosciences, Inc. (COGT) since IPO date, it would be worth $112.06 as of May 09, 2025 at a share price of $4.98. Whereas If you bought $1000 worth of Cogent Biosciences, Inc. (COGT) shares 5 years ago, it would be worth $2,766.67 as of May 09, 2025 at a share price of $4.98.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cogent Biosciences Reports First Quarter 2025 Financial Results
GlobeNewswire Inc.
May 06, 2025 12:00 PM GMT
Three Registration-Directed Top-line Data Readouts Remain on Track in 2025: SUMMIT in NonAdvanced SM expected in July, APEX in Advanced SM expected in second half of the-year and PEAK in GIST expected by end of year Ended 1Q 2025 with $245.7 million
Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders
GlobeNewswire Inc.
Apr 25, 2025 12:08 PM GMT
WALTHAM, Mass. and BOULDER, Colo., April 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced preclinical data from
Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire Inc.
Mar 25, 2025 8:31 PM GMT
Four abstracts accepted for poster presentation highlight Cogent’s expertise in pioneering best-in-class therapeuticsWALTHAM, Mass. and BOULDER, Colo., March 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology comp